Clinical trial · Observational
Urine Cytology and Utility in Bladder Recurrence
NCT00971256CI-TRIAL-00005805completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Review bladder cancer patients and form a database in regards to urine cytology.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Bladder cancer patients
- description
- Bladder cancer patients from one Beaumont Urologist.
Primary outcomes (1)
- measure
- Review bladder cancer patients and form a database in regards to urine cytology.
- timeFrame
- 1 month
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Bladder cancer patients from Dr. Jay Hollander's private practice. Exclusion Criteria: * Patients with diagnosis of bladder cancer without initial cytology available. * Patients who received outside nephrectomy or cystectomy without pathology available. * Those who had recurrence without cytology results available. * Those who were followed by Dr Hollander and another urologist in which records are missing for a significant number of follow ups.
References
Publications (0)
Data not yet available
No reference posted for this study.